Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 454 results for "cadila healthcare"

Pharma shares on a roll; BSE Healthcare index up 3%
Business Standard

Hepatitis C licence and drug firms

Strides Arcolab, Cadila Healthcare, Ranbaxy, Sequent Scientific and Cipla will remain in focus as Gilead Sciences Inc has granted licence to these firms to sell a Hepatitis C drug in developing countries. The tie-ups will allow them to make and sell ... Hindu Business Line, 5 days ago
[x]  

5 images for cadila healthcare

Financial Express, 1 month ago
Livemint.com, 1 month ago
Money Control, 1 month ago
Rediff.com, 2 months ago
Sify, 1 month ago
India TV

Zydus gets USFDA nod to market anti-diabetic tablets; closes down 1.15%

Cadila Healthcare closed today at 1.15% at Rs. 1,272 on BSE. The stock opened at Rs. 1,300 and closed at Rs. 1,272. The stock hit a high of Rs. 1323 and a low of Rs. 1,262. Zydus Cadila has received tentative approval from the USFDA to market ...
 India Infoline5 days ago Zydus gets tentative nod from USFDA to market diabetic tablets  India TV5 days ago Cadila Health up 3%, diabetic drug gets tentative USFDA nod  Moneycontrol.com5 days ago Zydus gets USFDA tentative nod for diabetic tablets  Press Trust of India5 days ago
[x]  
Reuters UK

After India success, Cadila to take innovator drug to US [DNA : Daily News & Analysis (India)]

[September 17, 2014] (DNA : Daily News & Analysis (India) Via Acquire Media NewsEdge) Mumbai: Cadila Healthcare will soon start filings for approval of its innovator drug Lipaglyn in advanced markets such as the US and Europe. The ...
 TMC Net3 days ago CADILA HEALTHCARE : Usfda raises concerns over production process at cadila  4 Traders1 month ago Cadila's Moraiya facility under US FDA lens  Business Standard India1 month ago Cadila Healthcare shares slump over 4 per cent; m-cap down Rs 960 crore  Economic Times1 month ago
[x]  

Cadila Healthcare eyeing US, Europe markets

Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon start filings for approval of its innovator drug Lipaglyn there. As per news reports, the drug is said to have current patients base ...
 Bio Spectrum Asia6 days ago Cadila to take innovator drug to US, Europe markets  DNA India6 days ago Cadila Healthcare to take innovator drug to US,Europe markets  DNA5 days ago
Business Standard India

Zydus Cadila bags license for hepatitis C drug

medabad-based pharma major Cadila Healthcare (Zydus Cadila) today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc, which will allow the generic manufacture of sofosbuvir and ledipasvir (used for treatment of ...
 Business Standard India5 days ago

Top 3 picks: Mindtree, IFB Industries, Cadila Healthcare

Mindtree Revenue has grown at an impressive CAGR of 26% during FY11-14, while PAT has grown at a CAGR of 64% in the same period. Mindtree is well poised for growth, given its strong domain expertise, investment in sales & marketing for better ...
 Financial Express5 days ago
Business Standard India

Novartis files lawsuit against Zydus for patent infringement in US

Ahmedabad-based Cadila Healthcare Ltd (Zydus Cadila) is facing lawsuits in US court, including that filed by global pharma major Novartis Pharmaceuticals, for infringement of patents. Novartis has filed two suits against Cadila Healthcare's US ...
 Business Standard India1 week ago

Cadila Healthcar - Zydus receives tentative approval for Gli...

The page you are looking for might have been removed, had its name changed, or is temporarily unavailable. Please try the following: Make sure that the Web site address displayed in the address bar of your browser is spelled and formatted ...
 SBICAP Securities5 days ago India : TENTATIVE Approval for Glipizide ER Tablets received by Zydus [TendersInfo (India)]  Pharmacy Choice3 days ago Cadila Healthcare announces tentative approval for Glipizide ER tablets  Business Standard5 days ago Zydus receives tentative approval for Glipizide ER tablets  Moneycontrol.com5 days ago
[x]  

Cadila Healthcare : Patent Issued for Method for Preparation of Pitavastatin and Pharmaceutical Acceptable Salts

By a News Reporter-Staff News Editor at Drug Week -- A patent by the inventors Dwivedi, Shriprakash Dhar ( Gujarat , IN); Patel , Dhimant Jasubhai ( Gujarat , IN); Shah, Alpesh Pravinchandra ( Gujarat , IN); Khera, Brij ( Princeton, NJ ), filed on ...
 4 Traders3 days ago Patent Issued for Method for Preparation of Pitavastatin and Pharmaceutical Acceptable Salts  Pharmacy Choice3 days ago

CADILA HEALTHCARE : "Pharmaceutical Compositions of Silodosin" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Biotech Week -- A patent application by the inventors Roy, Sunilendu Bhushan ( Gujarat , IN); Kulkarni, Sushrut Krishnaji ( Gujarat , IN); Handa, Ajay Kumar ( Gujarat , IN); Uma, Doss Pothuvan ( Gujarat , IN), ...
 4 Traders1 week ago CADILA HEALTHCARE : "Stable Pharmaceutical Compositions of an S1p Receptor Agonist" in Patent Application Approval Process  4 Traders1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cadila healthcare
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less